Clinical Trial Update: Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating prazosin and naltrexone (PaN) for veterans with alcohol use disorder and PTSD has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Posttraumatic Stress Disorder

Drugs mentioned

• Naltrexone (Naltrexone)
• Prazosin (prazosin)

Snippet

Sponsor: Seattle Institute for Biomedical and Clinical Research | Conditions: Alcohol Use Disorder, Posttraumatic Stress Disorder (PTSD) | Phase 2 | Status: COMPLETED | Results posted: 2020-12-29